Clinical trials
Withdrawn Phase 2 Hemolysis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
4 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2020 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 4 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Massachusetts General Hospital | 2 |
| Alnylam Pharmaceuticals | 1 |
| Kezar Life Sciences, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hemolysis | 4 |
| Thrombocytopenia | 2 |
| Anemia | 1 |
| Anemia, Hemolytic, Autoimmune | 1 |
| Atypical Hemolytic Uremic Syndrome | 1 |
| Cardiovascular Diseases | 1 |
| Hematologic Diseases | 1 |
| Hypertension, Pulmonary | 1 |
| Purpura, Thrombocytopenic, Idiopathic | 1 |
| Renal Insufficiency | 1 |
Trials
Showing 1 to 4 of 4. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.